Allosteric and Transport Mechanisms in TonB-dependent Transporters

TonB 依赖性转运蛋白的变构和转运机制

基本信息

  • 批准号:
    9019305
  • 负责人:
  • 金额:
    $ 38万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-12-01 至 2020-11-30
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): Active membrane transport of essential compounds such as molecules and proteins into the cell is a fundamental process in cellular physiology and is thus regulated by a number of different transport pathways. Gram-negative bacteria, mitochondria, and chloroplasts contain transmembrane β-barrel proteins on their outer membrane (OM), commonly referred to as outer membrane proteins (OMPs), that serve essential functions in cargo transport and signaling. A large and important family of OMPs are the TonB-dependent transporters (TBDTs). TBDTs are involved primarily in iron uptake, a metal that is essential for the growth and development of almost all living organisms. In addition, TBDTs also transport naturally occurring antibiotics, colicins and phages. Because iron transport systems are critical for the survival of a large number of pathogenic bacteria in vivo, TBDTs are attractive candidates for therapeutic intervention. Moreover, antibiotics are currently being produced that target TBDTs and rely on them for their transport inside the cell. Therefore, this system has attracted tremendous interest for medical and biotechnological reasons. Numerous studies have focused on dissecting the mechanisms underpinning transport of substrates through the pore of TBDTs. TBDTs share a common structure consisting of a transmembrane β-barrel and a globular domain, the so-called plug, that occludes the lumen of the barrel. The periplasmic N terminus of TBDTs contains a sequence, the so-called TonB box, which recruits the periplasmic domain of TonB. This binding event is absolutely essential for the transport. Over 50 crystal structures of TBDTs in various liganded states are available but in all of them the pore is always occluded. How TonB binding to TBDTs enables substrate translocation remains a mystery. We propose to use NMR spectroscopy to dissect the allosteric interactions and unravel the transport mechanisms in FhuA, a prototypic TBDT. We will obtain integrated structural, dynamic, kinetic and thermodynamic information of the interaction between physiological substrates and the FhuA transporter and study how TonB enables substrate translocation. We present very strong supporting data that the key processes can be characterized by NMR at the atomic level by the use of advanced NMR and isotope labeling methodologies. We aim to: (i) determine the structural dynamics of FhuA by NMR; (ii) characterize the effect of TonB binding on the structure and dynamics of FhuA; (iii) characterize the transport mechanisms of siderophores and antibacterial peptides; (iv) characterize the transport mechanisms of colicins. Successful completion of the specific aims outlined in this proposal will provide unprecedented and fascinating insight into the fundamental mechanisms that enable substrate transport by the large family of TBDTs. A comprehensive description of the structural and mechanistic basis of operation of these proteins will further advance our understanding of how allosteric membrane transporters function and how they are regulated.
 描述(由适用提供):基本化合物(例如分子和蛋白质)进入细胞的主动膜转运是细胞生理学中的一个基本过程,因此受许多不同转运途径的调节。革兰氏阴性细菌,线粒体和叶绿体在其外膜(OM)上含有跨膜β-桶蛋白,通常称为外膜蛋白(OMP),在货物运输和信号传导中起着基本功能。大而重要的OMP家族是TONB依赖性转运蛋白(TBDTS)。 TBDT主要参与铁吸收,这是一种金属,对于几乎所有活着组织的增长和发展至关重要。此外,TBDT还会运输自然存在的抗生素,绞痛和噬菌体。由于铁运输系统对于体内大量致病细菌的存活至关重要,因此TBDT是治疗干预的有吸引力的候选者。此外,目前正在生产抗生素,以靶向TBDT,并依靠它们在细胞内的运输。因此,出于医学和生物技术原因,该系统引起了极大的兴趣。许多研究集中在解剖通过TBDT孔通过底物运输的机制。 TBDT共享一个共同的结构,该结构由跨膜β-桶和一个全球域,即所谓的插头,它阻塞了枪管的管腔。 TBDT的周质N末端包含一个序列,即所谓的TONB盒子,该盒子募集了TONB的周质结构域。这个绑定事件对于运输绝对是必不可少的。在各种配体状态下,TBDT的50多个晶体结构都可以使用,但在所有配体状态下,孔总是被遮住。 TONB与TBDT的结合如何使底物易位仍然是一个谜。我们建议使用NMR光谱剖定原型TBDT FHUA中的变构相互作用并揭示运输机制。我们将获得物理底物与FHUA转运蛋白之间相互作用的综合结构,动态,动力学和热力学信息,并研究TONB如何实现底物转移。我们提供了非常强大的支持数据,即通过使用先进的NMR和同位素标记方法,在原子级别可以通过NMR来表征关键过程。我们的目标是:(i)确定NMR的FHUA结构动力学; (ii)表征TONB结合对FHUA结构和动力学的影响; (iii)表征了铁载体和抗菌辣椒的转运机制; (iv)表征核激素的运输机制。该提案中概述的特定目的的成功完成将为实现大型TBDT家族的底物运输的基本机制提供前所未有且引人入胜的见解。对这些蛋白质操作的结构和机械基础的全面描述将进一步提高我们对变构膜转运蛋白的功能及其调节方式的理解。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

CHARALAMPOS KALODIMOS其他文献

CHARALAMPOS KALODIMOS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('CHARALAMPOS KALODIMOS', 18)}}的其他基金

Structure and functional mechanisms of molecular chaperones and protein kinases
分子伴侣和蛋白激酶的结构和功能机制
  • 批准号:
    9920188
  • 财政年份:
    2017
  • 资助金额:
    $ 38万
  • 项目类别:
Structure and functional mechanisms of molecular chaperones and protein kinases
分子伴侣和蛋白激酶的结构和功能机制
  • 批准号:
    9515515
  • 财政年份:
    2017
  • 资助金额:
    $ 38万
  • 项目类别:
Structure and functional mechanisms of molecular chaperones and protein kinases
分子伴侣和蛋白激酶的结构和功能机制
  • 批准号:
    10552406
  • 财政年份:
    2017
  • 资助金额:
    $ 38万
  • 项目类别:
Allosteric and Transport Mechanisms in TonB-dependent Transporters
TonB 依赖性转运蛋白的变构和转运机制
  • 批准号:
    9188052
  • 财政年份:
    2015
  • 资助金额:
    $ 38万
  • 项目类别:
Structural insight into novel mechanisms of type III secretion
III 型分泌新机制的结构洞察
  • 批准号:
    8580192
  • 财政年份:
    2011
  • 资助金额:
    $ 38万
  • 项目类别:
Structural insight into novel mechanisms of type III secretion
III 型分泌新机制的结构洞察
  • 批准号:
    8775192
  • 财政年份:
    2011
  • 资助金额:
    $ 38万
  • 项目类别:
Structural insight into novel mechanisms of type III secretion
III 型分泌新机制的结构洞察
  • 批准号:
    10396532
  • 财政年份:
    2011
  • 资助金额:
    $ 38万
  • 项目类别:
Structural insight into novel mechanisms of type III secretion
III 型分泌新机制的结构洞察
  • 批准号:
    8298308
  • 财政年份:
    2011
  • 资助金额:
    $ 38万
  • 项目类别:
Structural insight into novel mechanisms of type III secretion
III 型分泌新机制的结构洞察
  • 批准号:
    8390463
  • 财政年份:
    2011
  • 资助金额:
    $ 38万
  • 项目类别:
Structural insight into novel mechanisms of type III secretion
III 型分泌新机制的结构洞察
  • 批准号:
    8253171
  • 财政年份:
    2011
  • 资助金额:
    $ 38万
  • 项目类别:

相似国自然基金

三种凤尾蕨属植物中吡咯生物碱及其抗菌和抗HCV病毒功能研究
  • 批准号:
    82360689
  • 批准年份:
    2023
  • 资助金额:
    32.00 万元
  • 项目类别:
    地区科学基金项目
基于乏氧增强型超声抗菌剂的细菌生物膜感染协同治疗研究
  • 批准号:
    22375101
  • 批准年份:
    2023
  • 资助金额:
    50.00 万元
  • 项目类别:
    面上项目
基于声动力的高效靶向抗菌剂开发及其用于幽门螺杆菌感染治疗的研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
非典型I-型聚酮类抗菌剂NFAT-133的芳构化机理
  • 批准号:
    32211530074
  • 批准年份:
    2022
  • 资助金额:
    10 万元
  • 项目类别:
脑靶向新型反义抗菌剂递送系统的构建、评价及其递送机理研究
  • 批准号:
    82202575
  • 批准年份:
    2022
  • 资助金额:
    30.00 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Slippery Nanoemulsion-Infused Polymer Coatings that Prevent Bacterial Fouling and Block Bacterial Virulence
光滑的纳米乳液注入聚合物涂层可防止细菌污染并阻止细菌毒力
  • 批准号:
    10667161
  • 财政年份:
    2023
  • 资助金额:
    $ 38万
  • 项目类别:
Dispersion and the Biofilm Matrix of Pseudomonas aeruginosa
铜绿假单胞菌的分散和生物膜基质
  • 批准号:
    10376850
  • 财政年份:
    2021
  • 资助金额:
    $ 38万
  • 项目类别:
Dispersion and the Biofilm Matrix of Pseudomonas aeruginosa
铜绿假单胞菌的分散和生物膜基质
  • 批准号:
    10570255
  • 财政年份:
    2021
  • 资助金额:
    $ 38万
  • 项目类别:
PK/PD Optimized Cephalosporins Based Treatment Regimens for Children With MDR-TB
基于头孢菌素的 PK/PD 优化儿童耐多药结核病治疗方案
  • 批准号:
    10449269
  • 财政年份:
    2019
  • 资助金额:
    $ 38万
  • 项目类别:
PK/PD Optimized Cephalosporins Based Treatment Regimens for Children With MDR-TB
基于头孢菌素的 PK/PD 优化儿童耐多药结核病治疗方案
  • 批准号:
    10004700
  • 财政年份:
    2019
  • 资助金额:
    $ 38万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了